Neutrophils play a critical role in innate immune defense, but their improper activation also contributes to tissue damage during autoimmune diseases such as rheumatoid arthritis ( 1 -5 ) . Neutrophils use several cell surface receptors to sense their environment including ␤ 2 integrins, immunoglobulin Fc receptors, various G protein -coupled (e.g., formyl peptide or chemokine) receptors, Toll-like receptors, and receptors for various proinfl ammatory cytokines.
Lymphocyte antigen receptors, Fc receptors of mast cells, and Fc ␥ receptors of macrophages use a common receptor-proximal signal transduction machinery consisting of the sequential activation of Src family kinases, immunoreceptor tyrosine-based activation motif (ITAM) containing transmembrane adapters, and the Syk or the ZAP-70 tyrosine kinase. Studies from other groups ( 6, 7 ) and our own unpublished observations indicate that neutrophil Fc ␥ receptors also use a receptor-proximal Src family -ITAM-bearing adaptor -Syk signaling pathway. We have recently shown that ␤ 2 integrins in neutrophils signal through a conceptually similar receptor-proximal pathway, using Src family kinases ( 8, 9 ) , two ITAM-bearing transmembrane adapters (DAP12 and the Fc receptor ␥ chain) ( 10 ) , and the Syk tyrosine kinase ( 11 ) . We and others have reported similar ITAMbased integrin signaling pathways in other cell types including macrophages ( 10 ) , platelets ( 12 ) , osteoclasts ( 13 ) , dendritic cells ( 14 ) , and microglia ( 15 ) . Collectively, integrins and Fc receptors in rheumatoid arthritis. Serum of aff ected mice can trigger the eff ector phase of the disease in otherwise normal mice (serum transfer arthritis) ( 26 ) , allowing a clear separation of the two phases of the disease.
Analysis of the K/B × N and other models of autoimmune arthritis revealed that innate immune mechanisms are of critical importance in the later eff ector phase of the disease ( 26 ) . Several studies using lineage depletion ( 27 -29 ) , genetic ( 30, 31 ) , or combined genetic/reconstitution ( 32, 33 ) approaches indicate that neutrophils play a critical role in the eff ector phase of various animal models of autoimmune arthritis. However, the molecular mechanisms of how neutrophils contribute to the disease are very poorly understood.
Several cell surface receptors have been shown to be involved in the pathogenesis of autoimmune arthritis in mice. These receptors include Fc ␥ receptors such as Fc ␥ RIII or Fc ␥ RI ( 34 -43 ) as well as members of the ␤ 2 integrin family ( 44, 45 ) . However, it is at present unclear how (e.g., through what intracellular signaling mechanisms) Fc receptors and integrins participate in the development of joint infl ammation.
The aforementioned results prompted us to test the role of PLC ␥ 2 in various in vitro neutrophil functions as well as in the development of neutrophil-mediated autoimmune arthritis in vivo. Our results indicate that PLC ␥ 2 is critically involved in integrin and Fc receptor-mediated neutrophil functions as well as in the neutrophil-mediated eff ector phase of autoimmune arthritis.
RESULTS

PLC ␥ 2 is the dominant PLC ␥ isoform and is phosphorylated downstream of Src family kinases and Syk in neutrophils
First, we tested the expression level of the two PLC ␥ isoforms in neutrophils and compared it to that in other cell types. As shown in Fig. 1 A , PLC ␥ 2 was expressed at comparable levels in WT murine neutrophils and splenocytes but at much lower levels in WT thymocytes. In contrast, PLC ␥ 1 was expressed in neutrophils at a much lower level than in the thymus or the spleen. Although these results suggested that PLC ␥ 2 is the predominant PLC ␥ isoform in neutrophils, they did not allow the quantitative assessment of the relative expression of the two proteins in these cells. Hence, the expression of PLC ␥ 1 and PLC ␥ 2 was titrated against known amounts of recombinant Myc-tagged versions of the two proteins ( Fig.  S1 A, available at http://www.jem.org/cgi/content/full/jem .20081859/DC1). Based on those studies, WT mouse neutrophils were estimated to contain 53 ± 26 ng PLC ␥ 2 ( n = 3) and 3.0 ± 1.2 ng PLC ␥ 1 ( n = 3) per 10 6 cells, indicating that the expression of PLC ␥ 2 is ‫ف‬ 18-fold higher than that of PLC ␥ 1 in these cells. The expression of the two isoforms was also tested in PLC ␥ 2 Ϫ / Ϫ neutrophils ( Fig. 1 B ) . Although no PLC ␥ 2 signal was observed in PLC ␥ 2 Ϫ / Ϫ cells, the expression of PLC ␥ 1 was not aff ected by the same mutation. The specifi city of the antibodies used was also confi rmed by the blocking eff ect of isoform-specifi c PLC ␥ -blocking peptides (Fig. S1 B) . Collectively, these results indicate than various hematopoietic lineages signal through a conceptually similar ITAM-based receptor-proximal tyrosine phosphorylation cascade (for review see reference 16 ). However, the signal transduction mechanisms downstream of this common receptor-proximal pathway are poorly understood.
Phosphoinositide-specifi c phospholipase C (PLC) enzymes catalyze the breakdown of the membrane lipid phosphatidylinositol-4,5-bisphosphate to inositol-3,4,5-trisphosphate and diacylglycerol, triggering a concomitant Ca 2+ signal and protein kinase C activation. Of the best known PLC isoforms, the PLC ␤ family is activated by G protein -coupled receptors, whereas the PLC ␥ family is activated downstream of tyrosine phosphorylation pathways. There are two known PLC ␥ isoforms: PLC ␥ 1 is ubiquitously expressed, whereas PLC ␥ 2 is preferentially expressed in the hematopoietic system. Genetic defi ciency of PLC ␥ 1 leads to embryonic lethality, likely as a result of defective erythropoiesis and vasculogenesis ( 17, 18 ) . In contrast, PLC ␥ 2-defi cient mice are viable, their principal phenotype being a profound defect in B cell development and function ( 19 ) .
Although PLC ␥ 2 is activated by various Fc receptors, its possible functional role downstream of those receptors is rather controversial. Genetic defi ciency of PLC ␥ 2 attenuates Fc receptor-mediated degranulation of mast cells ( 19, 20 ) but it does not aff ect extracellular signal-regulated kinase (ERK) activation or cytokine production under the same conditions ( 20 ) . Although PLC ␥ 2 is required for Fc ␥ receptor-triggered Ca 2+ signal in macrophages, PLC ␥ 2 Ϫ / Ϫ macrophages show normal phagocytosis of IgG-coated erythrocytes ( 20 ) . The role of PLC ␥ 2 in Fc receptor-mediated functions in other cell types such as neutrophils is presently unknown.
PLC ␥ 2 is also activated by integrins but its role in integrin signal transduction is also controversial. Although a statistically signifi cant decrease of spreading was reported in PLC ␥ 2 Ϫ / Ϫ platelets ( 21, 22 ) , that diff erence only accounted for a 30% reduction of the ␣ 2 ␤ 1 integrin-induced increase in cell surface area ( 21 ) or a delayed kinetics and moderately smaller percentage of full spreading on an ␣ IIb ␤ 3 integrin ligand surface ( 22 ) . Hence, PLC ␥ 2 appears to be a modulator rather than a critical component of integrin signaling in platelets. In contrast, a recent study focusing on the role of Vav family proteins in neutrophils suggested that PLC ␥ 2 downstream of Vav may be more directly involved in integrin signaling in these cells ( 23 ) .
Rheumatoid arthritis is a severe chronic autoimmune disease aff ecting ‫ف‬ 1% of the human population ( 24 ) . The disease is initiated by the emergence of autoreactive T cells (initiation or immunization phase), which then trigger the second (eff ector or tissue destruction) phase, mediated in large part by cells of the innate immune system. These two phases are very clearly separated in the K/B × N arthritis model ( 25 ) . This model is initiated by a transgenic autoreactive T cell receptor (KRN transgene) on the autoimmunity-prone MHC background from the NOD mouse strain. This initial phase leads to the generation of autoantibodies that trigger excessive joint infl ammation and destruction resembling human integrin ligand surface (poly-RGD) ( 11 ) triggered phosphorylation of PLC ␥ 2. Importantly, this phosphorylation response was absent in cells lacking the Src family kinases Hck, Fgr, and Lyn ( Fig. 1 C ) or the Syk tyrosine kinase ( Fig. 1 D ) . Murine neutrophils can also be activated in an Fc ␥ RIII/Fc ␥ RIVdependent manner by plating them on immobilized IgG immune complexes ( 46 ) , leading to cellular responses that are dependent on Src family kinases and Syk (unpublished data). As shown in Fig. 1 (E and F) , neutrophil activation by such immobilized immune complexes leads to phosphorylation of PLC ␥ 2 in WT but not in Src family -defi cient ( Fig. 1 E ) or Syk-defi cient ( Fig. 1 F ) neutrophils. These results suggest that PLC ␥ 2 is a downstream target of Src family kinases and Syk during both integrin and Fc receptor-mediated activation of neutrophils.
PLC ␥ 2 ؊ / ؊ bone marrow chimeras and neutrophil surface marker expression Our next aim was to test the role of PLC ␥ 2 in functional responses of neutrophils, using cells that are genetically defi cient of this phospholipase isoform. Because we (and others) have not been able to breed homozygous PLC ␥ 2 Ϫ / Ϫ mice (indicating a fertility defect in PLC ␥ 2 Ϫ / Ϫ males and/or females), the mutation was maintained in heterozygous (PLC ␥ 2 +/ Ϫ ) form. Even under such conditions, only 12% (rather than the expected 25%) of a total of 379 off springs from PLC ␥ 2 +/ Ϫ × PLC ␥ 2 +/ Ϫ matings were found to be of the PLC ␥ 2 Ϫ / Ϫ genotype at weaning age, indicating a partial defect in survival of PLC ␥ 2 Ϫ / Ϫ embryos or newborn pups, which is likely a result of a lymphatic vascular developmental defect ( 47 ) similar to that seen in SLP-76 Ϫ / Ϫ and Syk Ϫ / Ϫ mice ( 48 ) . To overcome this problem, bone marrow transplantation was used to generate chimeric mice with a PLC ␥ 2 Ϫ / Ϫ hematopoietic system. To this end, recipient mice carrying the CD45.1 allele on the C57BL/6 genetic background were lethally irradiated and then injected intravenously with isolated PLC ␥ 2 Ϫ / Ϫ or control C57BL/6 bone marrow cells (both donor strains carry the CD45.2 allele). Repopulation of the neutrophil compartment by donor-derived cells was confi rmed by fl ow cytometric analysis of the donor-specifi c CD45.2 allele in peripheral blood leukocytes 4 -5 wk after transplantation (Fig. S2 , available at http://www.jem.org/cgi/content/full/jem.20081859/DC1). Using this approach, 99.3 ± 1.6% ( n = 120) and 99.1 ± 2.4% ( n = 135) of peripheral blood neutrophils of WT and PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras, respectively, were found to be of donor origin. Though quite laborious, this approach allowed us to signifi cantly increase the number of mice available for our studies. Unless otherwise stated, all of the following experiments were performed using such WT and PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras.
We next tested whether the defi ciency of PLC ␥ 2 aff ected neutrophil development or expression of major cell surface receptors. Our bone marrow neutrophil isolation protocol yielded 12.1 ± 3.3 × 10 6 WT and 12.4 ± 4.8 × 10 6 PLC ␥ 2 Ϫ / Ϫ neutrophils per mouse ( n = 23; P = 0.62), indicating that the lack of PLC ␥ 2 did not cause a quantitative change in neutrophils express both PLC ␥ 1 and PLC ␥ 2, although PLC ␥ 2 is the predominant isoform. Furthermore, the genetic deficiency of PLC ␥ 2 does not aff ect the expression of PLC ␥ 1 in these cells.
We and others have previously shown that ␤ 2 integrins signal through a receptor-proximal tyrosine phosphorylation cascade involving Src family kinases and Syk ( 8 -11 ; for review see reference 16 ). Next, we tested whether PLC ␥ 2 is also phosphorylated under these conditions and whether Src family kinases and Syk participate in this process. As shown in Fig. 1 (C and D) , plating WT neutrophils on a polyvalent from PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras failed to produce superoxide when plated on a fi brinogen-coated surface in the presence of TNF. In a limited number of experiments, a similar defect was also seen in neutrophils isolated from intact (nonchimeric) PLC ␥ 2 Ϫ / Ϫ mice (Fig. S3 A, available at http://www.jem.org/cgi/content/full/jem.20081859/DC1). PLC ␥ 2 Ϫ / Ϫ neutrophils also failed to release the tertiary granule marker gelatinase ( Fig. 3 B ) or spread over the fibrinogen surface ( Fig. 3 C ) under identical conditions. A similar defect was seen when fi brinogen-adherent neutrophils were stimulated by other soluble proinfl ammatory agents, such as the TLR2 agonist lipopeptide Pam 3 CSK 4 , the TLR4-specifi c ligand ultrapurifi ed LPS, the GM-CSF cytokine, or the MIP-2 chemokine, which is the mouse homologue of human IL-8 ( Fig. 3 D ) , in a CD18-dependent manner (Fig. S4) .
Although both integrin ligation and a separate proinfl ammatory stimulus is required for maximal activation of adherent neutrophils under physiological conditions ( 49, 51 ) , ␤ 2 integrin -mediated in vitro neutrophil activation can also be achieved by plating the cells on surfaces coated with an engineered polyvalent integrin ligand (poly-RGD) in the absence of any additional stimulus ( 11 ) . PLC ␥ 2 Ϫ / Ϫ neutrophils failed to release superoxide when plated on a poly-RGD -coated surface ( Fig. 3 E ) and they did not spread on this polyvalent integrin ligand surface either ( Fig. 3 F ) .
Collectively, PLC ␥ 2 appears to be critically involved in the adhesion-dependent activation of neutrophils. Together with the fact that both TNF and the other soluble proinfl ammatory agonists signal normally in PLC ␥ 2 Ϫ / Ϫ neutrophils in suspension ( Fig. 4 ) , our results indicate that PLC ␥ 2 is required for signaling by integrins rather than by receptors of the soluble proinfl ammatory agents.
Neutrophils can also be activated by immobilized IgG immune complexes in an Fc ␥ RIII/Fc ␥ RIV-dependent manner ( 46 ) , mimicking their activation upon immune complex deposition in autoimmune diseases. Our unpublished observations indicate that this response also requires Src family kinases and Syk. As shown in Fig. 3 G , neutrophils isolated from PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras failed to release superoxide when plated on immobilized IgG immune complexes. Similar results were also obtained using neutrophils isolated from intact PLC ␥ 2 Ϫ / Ϫ mice (Fig. S3 B) . The PLC ␥ 2 Ϫ / Ϫ mutation also abrogated gelatinase release ( Fig. 3 H ) and neutrophil spreading ( Fig. 3 I ) under such conditions. Hence, PLC ␥ 2 is also critically involved in Fc ␥ receptor-mediated functional responses of neutrophils.
PLC ␥ 2 is not required for signaling by G protein -coupled receptors, Toll-like receptors, and various cytokine receptors Next, we tested integrin and Fc receptor-independent responses in PLC ␥ 2-defi cient neutrophils. As a fi rst approach, the cells were stimulated with the nonphysiological protein kinase C -activating agent PMA, which is known to activate neutrophils even in the absence of important cell surface receptors such as ␤ 2 integrins ( 11 ) or intracellular signaling molecules like neutrophil production. PLC ␥ 2 Ϫ / Ϫ neutrophils also expressed normal levels of the Gr1 granulocyte diff erentiation marker ( Fig. 2 A ) and the general leukocyte marker CD45 (Fig. S2) . The PLC ␥ 2 Ϫ / Ϫ mutation did not aff ect expression of the ␤ 2 integrin chain CD18 ( Fig. 2 B ) or the ␣ chains of LFA-1 (CD11a; Fig. 2 C ) or Mac-1 (CD11b; Fig. 2 D ) . There was no diff erence between the two genotypes in cell surface staining with a common Fc ␥ RII/Fc ␥ RIII-recognizing antibody ( Fig. 2 E ) or a monoclonal antibody against Fc ␥ RIV ( Fig.  2 F ) . Collectively, genetic defi ciency of PLC ␥ 2 did not aff ect neutrophil maturation or the expression of major cell surface integrins or Fc ␥ receptors.
PLC ␥ 2 is required for integrin and Fc receptor-mediated neutrophil functions
In the following experiments, the role of PLC ␥ 2 in in vitro neutrophil functions was investigated. Robust neutrophil activation can be achieved by plating the cells on an integrin ligand (e.g., fi brinogen)-coated surface in the presence of a soluble proinfl ammatory agonist, such as TNF ( 49 ), mimicking activation of neutrophils adherent to the extracellular matrix at the site of infl ammation. This response is completely dependent on ␤ 2 integrins both in humans ( 50 ) and mice ( 11 ) (see Fig. S4 ). As shown in Fig. 3 A , neutrophils obtained that PLC ␥ 2 is not required for distal steps of NADPH oxidase activation.
Robust integrin and Fc receptor-independent neutrophil activation can also be triggered by the bacterial formyl-peptide Src family kinases ( 9 ) or Syk ( 11 ) . PMA-stimulated PLC ␥ 2 Ϫ / Ϫ neutrophils, which were isolated either from PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras ( Fig. 4 A ) do not induce major functional responses (such as respiratory burst) in the absence of an integrin ligand surface (Fig. S4) , their integrin-independent signaling capacity was assessed by testing up-regulation of cell surface integrins or activation of intracellular signaling pathways in suspension. TNF triggered normal up-regulation of the CD18 or CD11b integrin chains ( Fig. 4 D ) , normal phosphorylation of the p38 MAP kinase ( Fig. 4 E ) , and normal phosphorylation and degradation of the NF-B pathway inhibitor I -B ␣ ( Fig. 4 E In the experiments presented in Fig. 3 , adhesion-dependent activation of neutrophils was tested in the presence of various soluble proinfl ammatory agonists. Because those agonists Collectively, PLC ␥ 2 is not required for integrin and Fc receptor-independent functional and signaling responses of neutrophils. These results also suggest that the defective adherent activation of PLC ␥ 2 Ϫ / Ϫ neutrophils ( Fig. 3 ) is caused by a defect in integrin signaling rather than that of the soluble proinfl ammatory agonists.
Normal migration of PLC ␥ 2-defi cient neutrophils
Neutrophil migration to the site of infl ammation is mediated by several cell surface receptors including chemokine/chemoattractant receptors and ␤ 2 integrins. Our previous studies indicated that Src family kinases and Syk, which are indispensable for various ␤ 2 integrin-dependent eff ector functions of neutrophils, are surprisingly not required for ␤ 2 integrin-mediated cell migration ( 11 ) . Those studies prompted us to test whether PLC ␥ 2 participates in ␤ 2 integrin-mediated migration of neutrophils.
In an in vitro Transwell assay system, PLC ␥ 2-defi cient neutrophils migrated as well as WT cells toward increasing concentrations of the bacterial tripeptide f MLP through a fi brinogen-coated polycarbonate membrane of 3-μ m pore size ( Fig. 5 A ) . Because neutrophil migration under these conditions requires ␤ 2 integrins ( 11 ), these results indicate that PLC ␥ 2 is not required for ␤ 2 integrin-mediated neutrophil migration in vitro.
A competitive migration assay during a sterile peritonitis ( 11 ) was used to assess the in vivo migration of PLC ␥ 2 Ϫ / Ϫ neutrophils. To this end, mixed bone marrow chimeras carrying both CD45.2-expressing PLC ␥ 2 +/+ or PLC ␥ 2 Ϫ / Ϫ cells, along with CD45.1-expressing PLC ␥ 2 +/+ cells in their hematopoietic compartment, were generated. After the induction of a sterile peritonitis by intraperitoneal injection of sterile thioglycollate broth, the percentage of neutrophils from the two donor genotypes was determined both in the bloodstream and the peritoneal infi ltrate. Any diff erence in this percentage between the two compartments would indicate diff erent migratory capacities of neutrophils from the two donor strains. When both CD45.1-and CD45.2-expressing donor cells were of PLC ␥ 2 +/+ genotype, the percentage of CD45.2-expressing neutrophils did not diff er between the blood and the peritoneum ( Fig. 5 B ) , indicating that the diff erent alleles of CD45 do not aff ect neutrophil migration. In contrast, when CD45.2-expressing PLC ␥ 2 Ϫ / Ϫ bone marrow cells and CD45.1-expressing PLC ␥ 2 +/+ cells were present the percentage of PLC ␥ 2 Ϫ / Ϫ cells in the infl amed peritoneum was consistently higher than that in the bloodstream ( Fig. 5 B ) . Calculation of the relative migratory capacity of neutrophils revealed that the accumulation of PLC ␥ 2 Ϫ / Ϫ neutrophils in the infl amed peritoneum was nearly twice more effi cient than that of PLC ␥ 2 +/+ cells ( Fig. 5 C ) . These results are in sharp contrast with the severe reduction of migration of CD18 Ϫ / Ϫ neutrophils in a similar assay ( 11 ) . Therefore, in contrast to CD18, PLC ␥ 2 is not required for, or may even act as a negative regulator of, neutrophil migration into the infl amed peritoneum. Collectively, these results indicate that, similar to Src family kinases and Syk, PLC ␥ 2 is not required for CD18-dependent in vitro or in vivo migration of neutrophils.
to the vessel wall, no such eff ect was observed in PLC ␥ 2 Ϫ / Ϫ chimeras ( Fig. 6 A ) . fMLP also induced the spreading of WT leukocytes, as indicated by the fl attening (decreased diameter perpendicular to the vessel wall) of the cells adherent to the endothelium ( Fig. 6 B ) . This spreading (fl attening) response was strongly reduced in PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras at early time points ( Fig. 6 B ) , although the mutant cells were able to partially fl atten down at later time points after fMLP stimulation. Besides these real-time in vivo microscopic observations, parallel cremaster muscle samples were subjected to whole mount histological analyses. Those studies again revealed that the fMLP-induced increase of the intravascular leukocyte count (an approximate measure of leukocyte adhesion) was signifi cantly attenuated in PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras ( Fig. 6 C ) , likely refl ecting the described adhesion/spreading defect ( Fig. 6, A and B ) . Despite all these observations, the fMLP-induced increase of the number of perivascular leukocytes (an approximate measure of leukocyte extravasation) in PLC ␥ 2 Ϫ / Ϫ chimeras was similar to or even slightly higher than that in WT control chimeras ( Fig. 6 D ) ,
Leukocyte -endothelial interaction in fMLP-treated cremaster muscles in vivo
To gain further insight into the relationship between spreading, adherent activation, and cell migration in neutrophils, as well as to exclude the possibility that the aforementioned differences between the role of PLC ␥ 2 in these processes (compare Figs. 3 and 5 ) stem from the very diff erent assay systems used, we performed the simultaneous analysis of leukocyte adhesion, spreading, and extravasation in individual venules of fMLP-superfused cremaster muscles of WT and PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras. As shown in Table S1 (available at http://www.jem.org/cgi/content/full/jem.20081859/DC1), there was no diff erence in the various hemodynamic parameters or total leukocyte counts between the two genotypes. The PLC ␥ 2 Ϫ / Ϫ mutation did not aff ect rolling fl ux fraction (36 ± 11 and 28 ± 12% in WT and PLC ␥ 2 Ϫ / Ϫ chimeras, respectively) or leukocyte adhesion ( Fig. 6 A ) under resting conditions either. However, although local superfusion of the cremaster muscle of WT chimeras with 1 μ M fMLP triggered a signifi cant increase in stable adhesion of leukocytes treated PLC ␥ 2 Ϫ / Ϫ chimeras ( Fig. 7 A ) , indicating a major role for PLC ␥ 2 in the development of K/B × N serum transfer arthritis. Quantifi cation of arthritis severity by clinical scoring revealed that arthritis became evident 2 d after injection of WT chimeras with arthritogenic serum, peaked between 8 -12 d, and started to cease afterward. Importantly, no signs of arthritis were seen at any time point in PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras injected with arthritogenic K/B × N mouse serum ( Fig. 7 B ) . Treatment of WT chimeras with arthritogenic serum also triggered a robust increase of their ankle thickness ( Fig. 7 C ) , whereas the same treatment had no eff ect on ankle thickness of PLC ␥ 2 Ϫ / Ϫ chimeras ( Fig. 7 C ) . Collectively, PLC ␥ 2 within the hematopoietic compartment is indispensable for the development of macroscopic signs of autoimmune arthritis in the K/B × N serum transfer model. involved in the pathogenesis of infl ammatory diseases mediated by these factors. To test this possibility, we turned to the K/B × N serum transfer arthritis model, an autoantibody-mediated model of the eff ector phase of autoimmune arthritis. Prior studies from other groups indicated that this model requires neutrophils ( 27, 32, 33 ) as well as the presence of ␤ 2 integrins ( 44 ) and Fc ␥ receptors ( 34 -41 ) . We have also confi rmed the latter two conclusions (unpublished data).
To test the role of PLC ␥ 2 in the K/B × N serum transfer arthritis model, WT or PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras were injected with arthritogenic K/B × N serum or normal serum from nonarthritic (KRN transgene negative) littermates. Although WT bone marrow chimeras injected with arthritogenic serum developed severe arthritis of their hind paws ( Fig. 7 A ) , no sign of the disease was seen in similarly 
DISCUSSION
Rheumatoid arthritis is a severe chronic disease aff ecting ‫ف‬ 1% of the human population. Although the therapy of the disease has signifi cantly improved during the last decades, it is still far from being solved. This is exemplifi ed by the still widespread use of the highly cytotoxic chemotherapeutic agent methotrexate, the severe cardiovascular complications of COX-2 inhibitors, or the tremendous costs and possible side eff ects (e.g., reactivation of silent tuberculosis) of anti-TNF therapeutics. Better understanding of rheumatoid arthritis at the molecular level would strongly facilitate the development of novel treatment strategies for the disease.
The experiments presented in this paper provide evidence for the role of PLC ␥ 2 in the K/B × N arthritis model, one of the most widely used animal models of rheumatoid arthritis. A unique feature of this model is that its eff ector phase can be clearly separated from its initiation phase by transferring the serum of an arthritic K/B × N mouse to an otherwise nonarthritic recipient ( 26 ) . Our experiments performed using this serum transfer model ( Figs. 7 and 8 ) indicate that PLC ␥ 2 participates in the eff ector phase of the disease. Furthermore, the fact that bone marrow chimeras with PLC ␥ 2 Ϫ / Ϫ hematopoietic system but PLC ␥ 2 +/+ nonhematopoietic tissues are protected from K/B × N serum transfer arthritis indicates that PLC ␥ 2 within the hematopoietic system is indispensable for disease development.
The eff ector phase of rheumatoid arthritis is mediated by several cell types, likely including various phagocytic lineages. To our knowledge, of those lineages only neutrophils have been consistently linked to the development of the infl ammatory process in a diverse array of arthritis models and experimental approaches ( 27 -33 ) . Of the other phagocytes, liposome-mediated depletion studies suggested a pathogenetic role for macrophages ( 53 ) , but another genetic study indicated that certain macrophage subsets play a negative rather than a positive role in autoimmune arthritis ( 54 ) . Although an elegant series of genetic and reconstitution studies indicated the role of mast cells in the development of K/B × N serum transfer arthritis ( 55 ), another study using a diff erent genetic approach suggested that arthritis development may proceed normally in the absence of mast cells ( 56 ) . Based on these results, the most likely explanation for our in vivo results is that PLC ␥ 2 within neutrophils is required for the autoantibody-induced infl ammation process. The second most likely PLC ␥ 2-dependent compartment would be the mast cell lineage, which also expresses PLC ␥ 2 and may be activated through integrins and Fc ␥ receptors. However, because mast cells are long-lived radioresistant cells that survive a lethal irradiation in most tissues ( 57, 58 ) , it is unlikely that our bone marrow transplantation approach was able to replace the majority of the recipients ' mast cells. Hence, it unlikely that the complete defect of arthritis development in PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras is caused solely by the defi ciency of PLC ␥ 2 in mast cells.
Several cell surface receptors have also been shown to participate in various models of autoimmune arthritis. Several
To exclude the possibility that these results were aff ected by the bone marrow transplantation approach (e.g., by the use of irradiation that by itself may aff ect the course of autoimmune arthritis [reference 52 ]), the same experiments were repeated on a small cohort of intact (nonchimeric) WT and PLC ␥ 2 Ϫ / Ϫ mice. As shown in Fig. 7 (D -F) , genetic deficiency of PLC ␥ 2 completely abrogated the development of all clinical signs of K/B × N serum transfer arthritis even in such nonchimeric animals.
We also performed histological analysis of the ankle joint of bone marrow chimeras of the various experimental groups. As shown in Fig. 7 G , a robust leukocytic infi ltration of the periarticular tissues could be observed in WT chimeras injected with arthritogenic serum relative to those injected with nonarthritogenic control serum. Importantly, no such infi ltration was seen in PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras injected with arthritogenic serum ( Fig. 7 G ) , indicating that PLC ␥ 2 is required for the development of microscopic signs of arthritis such as the accumulation of leukocytes in the periarticular space.
PLC ␥ 2 ؊ / ؊ bone marrow chimeras are protected from arthritis-induced loss of articular function Besides the macroscopic and microscopic signs of infl ammation, arthritis also leads to severe impairment of articular function. This was assessed by testing the ability of the mice to hold on to the bottom of a horizontal wire grid similar to a regular wire cage lid. As shown in the video snapshots in Fig. 8 A , although WT chimeras injected with control serum were able to hold on to the wire grid for the entire 20-s assay period, WT chimeras injected with arthritogenic serum were not able to hold on for more than a few seconds, indicating an arthritis-induced loss of articular function. Importantly, PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras injected with arthritogenic serum had no diffi culties in holding on to the wire grid for the entire assay period ( Fig. 8 A ) .
To obtain a more quantitative assessment of joint function, this experiment was repeated several times on each individual mouse during the plateau phase of the disease, and the percentage of mice that were still holding on to the wire grid at a given time point was calculated analogous to Kaplan-Meier survival curves ( Fig. 8 B ) . As shown in Fig. 8 B , nearly 90% of control-treated WT chimeras held on to the wire grid until the end of the 20-s assay period. In contrast, only 40% of WT chimeras injected with arthritogenic serum held on for > 1 s, and practically none of them did so for the entire assay period ( Fig. 8 B ) . Importantly, most of the PLC ␥ 2 Ϫ / Ϫ chimeras were able to hold on to the wire grid for the entire 20-s period irrespective of whether they were injected with arthritogenic or control serum ( Fig. 8 B ) . In a small set of experiments, a similar protection from arthritis-induced loss of articular function was seen in intact (nonchimeric) PLC ␥ 2 Ϫ / Ϫ mice ( Fig. 8 C ) , indicating that the eff ect of PLC ␥ 2 defi ciency on articular function was not aff ected by the bone marrow transplantation approach used. Collectively, mice lacking PLC ␥ 2 are also protected from arthritis-induced loss of articular function.
absent. Similar studies on PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras presented in this paper also indicate that severely defective adhesion ( Fig. 6, A and C ) , and decreased and delayed spreading ( Fig. 6 B ) do not necessarily hinder the extravasation ( Fig. 6 D ) of leukocytes. Hence, transmigration of leukocytes through the vessel wall is possible even if adhesion and spreading are severely defective. It is at present unclear how transendothelial migration occurs under these conditions. One possibility is that integrin-mediated spreading and fi rm adhesion simply coincide with concomitant transmigration without any major role of the former two processes in the latter one. Alternatively, spreading and adhesion may play dual roles by promoting transmigration, for example, through arresting the leukocytes at the site of infl ammation, but also hindering it, for example, by holding leukocytes back by the adhesive process. If so, then a defective adhesion/spreading response would not have any major net eff ect on transmigration of leukocytes. Further studies will be required to reveal whether and how these or other mechanisms can explain transmigration of leukocytes when their spreading and/or adhesion responses are severely impaired.
Along the same line of thinking, it is also interesting to note that our histological analyses showed a complete lack of leukocytic infi ltration in periarticular regions of PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras injected with arthritogenic K/B × N serum ( Fig. 7 G ) . Based on the normal migration of PLC ␥ 2 Ϫ / Ϫ neutrophils under other conditions ( Figs. 5 and 6 ), we hypothesize that the lack of PLC ␥ 2 blocks the development of the infl ammatory environment (chemokines, cytokines, and infl ammatory endothelium). Hence, the otherwise migrationcompetent neutrophils are not attracted to the periarticular tissues in PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras.
All of the experiments presented in this paper have been performed on inbred mice on the C57BL/6 genetic background. This strain is the most widely used genetically homogeneous mouse strain, allowing the most accurate comparison of our results with those from other investigators. However, we cannot exclude the possibility that PLC ␥ 2 would be less critically involved in in vitro neutrophil functions and/or the eff ector phase of autoimmune arthritis on a diff erent genetic background. Such a phenomenon could theoretically be possible through compensation by either PLC ␥ 1 or a PLC ␥ -independent mechanism. Although it would be rather diffi cult to predict the possible extent of compensation by the latter mechanism, studies showing that overexpression of PLC ␥ 1 in PLC ␥ 2 Ϫ / Ϫ cells was not able to restore B cell maturation ( 64 ) or the development of multinucleated osteoclasts ( 65 ) suggest that there is relatively little room for functional compensation between the two members of the PLC ␥ family.
In addition to providing clear evidence for a role of PLC ␥ 2 in integrin-mediated neutrophil functions and the development of K/B × N serum transfer arthritis, our studies also raise several novel questions that have yet to be addressed in the future. Although we hypothesize that the eff ect of the PLC ␥ 2 Ϫ / Ϫ mutation in vivo is a result of a neutrophil defect, this has yet to be confi rmed more directly, for example, by studies using mice lacking the Fc receptor common ␥ chain ( 34 -37 ) or Fc ␥ receptor-specifi c ligand binding ␣ chains ( 36 -42 ) indicated a critical role for Fc ␥ receptors in various autoimmune arthritis models ( 43 ) . The role of ␤ 2 integrins ( 44 ) or their putative ligands ( 44, 45 ) has also been shown in various autoimmune arthritis models. Somewhat surprisingly, however, there is very little information available on whether and to what extent signaling molecules downstream of these receptors play a role in the development of autoimmune arthritis. In this context, it is particularly important that our study identifi es PLC ␥ 2, a component of integrin and Fc receptor signal transduction, as a critical player of the eff ector phase of autoimmune arthritis.
Neutrophils are critical players of the innate immune response but they also participate in tissue destruction during autoimmune diseases ( 1 -3, 5 ). Integrins and Fc receptors are two major groups of cell surface receptors participating in neutrophil activation at the site of infl ammation or bacterial invasion. We and others have shown that integrin and Fc receptor signaling in neutrophils are both mediated by a receptor-proximal tyrosine phosphorylation cascade consisting of Src family kinases, ITAM-bearing adaptor molecules, and the Syk tyrosine kinase ( 6 -11 ; for review see reference 16 ) (unpublished data). In the present work, we identify PLC ␥ 2 as a common downstream mediator of integrin and Fc receptor signaling in neutrophils ( Fig. 3 ) . PLC ␥ 2 thus appears to be a new member of a growing family of intracellular molecules participating in both integrin and Fc receptor signal transduction in these cells ( 6 -11, 59 -61 ; for review see reference 16 ). In contrast, PLC ␥ 2 is dispensable for neutrophil activation through several other cell surface receptors such as G protein -coupled formyl peptide or chemokine receptors, various cytokine receptors (TNF and GM-CSF), or members of the Toll-like receptor family ( Fig. 4 ) . Hence, PLC ␥ 2 plays a specifi c role in signaling by a defi ned subset of neutrophil activatory receptors.
In addition to participating in adhesion-dependent functional responses of neutrophils, ␤ 2 integrins are also required for the migration of the cells to the site of infl ammation. Somewhat surprisingly, although PLC ␥ 2 is required for the former response ( Fig. 3 ) , ␤ 2 integrin-mediated ( 11 ) neutrophil migration can occur in the absence of PLC ␥ 2 ( Fig. 5 ) . This is, however, in line with the normal migration of neutrophils lacking Src family kinases ( 11 ), Syk ( 11 ), ITAM-bearing adapters ( 10 ), or members of the Vav family ( 60 ) under CD18-dependent conditions ( 11 ) . Therefore, ␤ 2 integrins likely use other PLC ␥ 2-independent pathways to support neutrophil migration to the site of infl ammation.
It is also puzzling how and to what extent spreading and extravasation can be dissected at the cellular and molecular level, given the generally accepted view that spreading and fi rm leukocyte adhesion precedes the transmigration of leukocytes through the vessel wall. Our prior studies on leukocyteendothelial interactions in Syk Ϫ / Ϫ bone marrow chimeras ( 62, 63 ) indicated that a signifi cant level of extravasation is possible even when adhesion is severely reduced and leukocyte spreading over the endothelium is apparently completely ton, TX). Fc receptor ␥ chain -defi cient ( Fcer1g tm1Rav/tm1Rav , referred to as FcR ␥ Ϫ / Ϫ ) mice ( 72 ) were purchased from Taconic. All these mice were backcrossed to the C57BL/6 genetic background for eight or more generations. WT control C57BL/6 mice were purchased from the Hungarian National Institute of Oncology. NOD mice, as well as a congenic strain carrying the CD45.1 allele on the C57BL/6 genetic background (B6.SJLPtprc a ), were purchased from The Jackson Laboratory. Mice were kept in individually sterile ventilated cages (Tecniplast) in a conventional facility. All animal experiments were approved by the Semmelweis University (Budapest, Hungary) Animal Experimentation Review Board or the Regierungspr ä sidium Karlsruhe (Karlsruhe, Germany).
To obtain bone marrow chimeras with PLC ␥ 2 Ϫ / Ϫ hematopoietic system, recipients carrying the CD45.1 allele on the C57BL/6 genetic background were lethally irradiated by 11 Gy from a 60 Co source using an irradiator (Gammatron 3; Siemens) and then injected intravenously with unfractionated bone marrow cells from PLC ␥ 2 Ϫ / Ϫ or WT C57BL/6 control mice. On average, bone marrow cells of a single donor mouse were injected into 10 -12 recipients. 4 -6 wk after transplantation, peripheral blood samples were stained for Gr1 and CD45.2 and analyzed by fl ow cytometry (see Flow cytometry). Repopulation of the hematopoietic compartment by donorderived cells was defi ned as the percentage of CD45.2-positive (donorderived) cells in the Gr1-positive granulocyte gate. Bone marrow chimeras were used 5 -10 wk after the transplantation.
Neutrophil isolation. Mouse neutrophils were isolated from the bone marrow of the femurs and tibias by hypotonic lysis followed by Percoll (GE Healthcare) gradient centrifugation as previously described ( 73 ) . Neutrophil isolation was performed at room temperature using sterile and endotoxinfree reagents. Cells were kept at room temperature in Ca 2+ -and Mg 2+ -free medium until use (usually less < 30 min) and prewarmed to 37 ° C before activation. Neutrophil assays were performed at 37 ° C in Hank ' s balanced salt solution (Invitrogen) supplemented with 20 mM Hepes, pH 7.4.
Flow cytometry.
For neutrophil studies, isolated neutrophils, peripheral blood samples, or peritoneal lavage fl uids were stained with PE-conjugated anti-Gr1 (RB6-8C5), FITC-conjugated anti-CD45.2 (clone 104), biotinylated anti-CD11b (M1/70), or unconjugated antibodies against CD18 (C71/16), CD11a (M17/4), Fc ␥ RII/III (2.4G2), or Fc ␥ RIV (9E9; obtained from J. Ravetch, Rockefeller University, New York, NY) ( 74 ) . To identify KRN transgene-positive mice, peripheral blood samples were labeled with FITC-conjugated anti-CD4 (RM4-5) and PE-conjugated anti-TCR V ␤ 6 (RR4-7) antibodies. Unconjugated antibodies were visualized with FITCconjugated anti -rat IgG whereas biotinylated anti-CD11b was visualized with streptavidin-Cy3 (Jackson ImmunoResearch Laboratories). Unless otherwise stated, all fl ow cytometry antibodies and their isotype controls were purchased from BD. All staining was performed in the presence of 2% FCS (Invitrogen). Samples were fi xed in FACS Lysing Solution (BD) and analyzed on a FACSCalibur (BD) using CellQuest software (BD). Neutrophils and CD4-positive T cells were identifi ed based on positive labeling for Gr1 and CD4, respectively, along with their typical forward-and side-scatter characteristics.
In vitro functional assays. Adhesion-dependent activation was performed by stimulating murine neutrophils with 50 ng/ml of recombinant murine TNF (PeproTech), 1 μ g/ml Pam 3 CSK 4 (EMC Microcollections), 5 μ g/ml of ultrapurifi ed LPS (InvivoGen), 10 ng/ml of recombinant murine GM-CSF (PeproTech), or 100 ng/ml of recombinant murine MIP-2 (PeproTech) while adherent to a plastic surface coated with 150 μ g/ml of human fi brinogen (MP Biomedicals) as previously described ( 10, 11 ) . Integrin-mediated activation in the absence of another soluble stimulus was achieved by plating neutrophils on surfaces precoated with 20 μ g/ml of engineered polyvalent integrin ligand peptide (poly-RGD; F5022; Sigma-Aldrich) Neutrophil activation by immobilized immune complexes was achieved by plating the cells on immobilized HSA -anti-HSA (both obtained from Sigma-Aldrich) immune complexes without any additional stimulus as previously described ( 46 ) . Activation of neutrophils in suspension was performed in Mg 2+ -free lineage-specifi c deletion of PLC ␥ 2 in neutrophils. The same holds true for whether our in vivo phenotype is indeed caused by an integrin and/or Fc receptor signaling defect and whether PLC ␥ 2 Ϫ / Ϫ neutrophils are indeed capable of migrating to the site of infl ammation during a full-blown K/B × N serum transfer arthritis. Although our studies strongly implicate PLC ␥ 2 in the eff ector phase of autoantibody-mediated arthritis, its contribution to other aspects of the disease have yet to be tested, for example, using the TNF-mediated human TNF-transgenic Tg197 ( 66 ) or the IL-17 -mediated SKG point mutant ( 67, 68 ) models. It is also unclear whether the lipase activity and/or other structural features of PLC ␥ 2 contribute to its role in neutrophil functions in vitro and arthritis development in vivo. This, and the reason for why PLC ␥ 1 is apparently not able to compensate for the lack of PLC ␥ 2, will need to be tested by reexpression of various PLC ␥ 2 mutants and/or PLC ␥ 1 in PLC ␥ 2 Ϫ / Ϫ bone marrow cells, for example, by using a retroviral reconstitution strategy ( 10 ) . Finally, the role of PLC ␥ 2 in the various aspects of antimicrobial functions of leukocytes (such as phagocytosis by myeloid lineage cells) and its relationship to that of Src family kinases and Syk has yet to be tested in more detail.
Collectively, we found that PLC ␥ 2 is a central component of integrin and Fc receptor signal transduction in neutrophils, linking the receptor-proximal Src family -ITAM adaptor -Syk cascade to functional responses of these cells. Our results also identify PLC ␥ 2 as a critical player of the eff ector phase of autoimmune arthritis, most likely through its role in integrin and Fc receptor signaling of neutrophils. These studies provide novel insight into the cellular and molecular mechanisms of autoimmune infl ammation and may eventually point to novel targets of future therapies of major human diseases such as rheumatoid arthritis.
MATERIALS AND METHODS
Animals.
Heterozygous mice carrying a deleted PLC ␥ 2 allele ( PLCg2 tm1Jni , referred to as PLC ␥ 2 Ϫ ) ( 19 ) were obtained from J. Ihle (St. Jude Children ' s Research Hospital, Memphis, TN). Because of the limited fertility and survival of homozygous PLC ␥ 2 Ϫ / Ϫ mice, the mutation was maintained in heterozygous form by a PLC ␥ 2 +/ Ϫ × PLC ␥ 2 +/ Ϫ breeding strategy. Offsprings were genotyped by allele-specifi c PCR reaction from tail DNA using 5 Ј -GCCTCTGCACAGCACACATATGG-3 Ј WT-specifi c and 5 Ј -CAA-GGTGAGATGACAGGAGATCC-3 Ј mutant-specifi c forward primers along with the 5 Ј -TTCACCGCATCCTCCTTTGAGTCC-3 Ј common reverse primer. Triple Src family -defi cient ( Hck tm1Hev/tm1Hev Fgr tm1Hev/tm1Hev -Lyn tm1Sor/tm1Sor , referred to as Hck Ϫ / Ϫ Fgr Ϫ / Ϫ Lyn Ϫ / Ϫ ) mice ( 69 ) were obtained from C. Lowell (University of California, San Francisco, San Francisco, CA) and kept as triple homozygous mutants. Mice carrying the Syk tm1Tyb mutation ( 70 ) (referred to as the Syk Ϫ allele) were obtained from V. Tybulewicz (National Institute for Medical Research, London, UK). The Syk Ϫ mutation was maintained in heterozygous form and used to obtain Syk Ϫ / Ϫ neutrophils by fetal liver transplantation as previously described ( 11 ) . Mice carrying the KRN T cell receptor transgene ( 25 ) were obtained from D. Mathis and C. Benoist (Harvard Medical School, Boston, MA) and maintained in heterozygous form by mating with C57BL/6 mice. KRN transgene-positive mice were identifi ed by fl ow cytometry (see Flow cytometry) based on the high percentage of V ␤ 6 TCR-expressing cells among CD4-positive T cells ( 25 ) . Complete CD18-defi cient ( Itgb2 tm2Bay/tm2Bay , referred to as CD18 Ϫ / Ϫ ) mice ( 71 ) were obtained from A. Beaudet (Baylor College of Medicine, Hous-migration of neutrophils into the lower compartment during a 60-min period was assessed by an acid phosphatase assay as previously described ( 11 ) .
A competitive migration assay during sterile peritonitis in mixed bone marrow chimeras ( 11 ) was used to assess in vivo migration of neutrophils. To this end, bone marrow cells of PLC ␥ 2 Ϫ / Ϫ mice on the C57BL/6 genetic background (i.e., carrying the CD45.2 allele) were mixed with bone marrow cells from congenic mice expressing CD45.1 on the C57BL/6 genetic background at varying ratios ranging from 10 to 70% of CD45.2-expressing cells. This mixed cell suspension was injected intravenously into lethally irradiated CD45.1-expressing recipient mice, giving rise to mixed bone marrow chimeras carrying CD45.2-expressing PLC ␥ 2 Ϫ / Ϫ and CD45.1-expressing PLC ␥ 2 +/+ hematopoietic cells. To exclude any eff ect of the diff erent CD45 alleles on cell migration, a few control chimeras were generated in a similar fashion but using PLC ␥ 2 +/+ (intact C57BL/6) mice as the CD45.2-expressing donor strain, giving rise to mixed chimeras with CD45.1-and CD45.2-expressing PLC ␥ 2 +/+ hematopoietic cells. 5 -8 wk after transplantation, the mixed bone marrow chimeras were injected intraperitoneally with 1 ml of 3% thioglycollate broth (Heipha Diagnostics). Blood was taken directly before as well as 2 and 4 h after the injection, and the peritoneal cavity was lavaged at 4 h. The relative percentage of CD45.1-and CD45.2-expressing neutrophils in the peripheral blood and peritoneal lavage samples was determined by fl ow cytometry in the Gr1-positive granulocyte gate. Relative migration of neutrophils of the CD45. Intravital microscopy and whole mount cremaster muscle preparation. Bone marrow chimeras were anesthetized using intraperitoneal injection of ketamine and xylazine and the cremaster muscle was prepared for intravital imaging as previously described ( 63 ) . Intravital microscopy was performed on an upright microscope (BX51; Olympus) with a 40 × 0.75 NA saline immersion objective. The microcirculation was recorded using a chargecoupled device camera (CF8/1; Kappa) coupled to a recorder (S-VHS; Panasonic). Superfusion of the cremaster muscle and local treatment with 1 μ M fMLP was performed as previously described ( 63 ) . Postcapillary venules ranged from 25 to 35 μ m in diameter and were observed before and during f MLP administration.
Geometric and hemodynamic parameters, such as vessel diameter, leukocyte diameter, and vessel segment length, of postcapillary venules were assessed from recorded video tapes using a digital image processing system as previously described ( 77 ) . Spreading of adherent leukocytes in postcapillary venules was assessed by measuring the diameter (height) of attached leukocytes perpendicular to the vessel wall before and at various time points during f MLP superfusion as previously described ( 63 ) . Mean blood fl ow velocities and wall shear rates ( ␥ w ) were estimated as previously described ( 63 ) . Rolling leukocyte fl ux fraction was defi ned as the ratio of rolling leukocytes to the total number of leukocytes passing the same vessel per minute ( 78 ) . Leukocyte adhesion was defi ned as the number of adherent cells per millimeters squared of vessel surface area ( 63 ) . Systemic leukocyte concentration was determined from blood samples taken at the end of the experiment as previously described ( 63 ) .
For whole mount preparations, mouse cremaster muscles were surgically prepared, as described in the fi rst paragraph of this section, and superfused with 1 μ M f MLP in superfusion buff er for 15 min. Thereafter, cremaster muscles were fi xed with 4% paraformaldehyde and whole mounts were prepared as previously described ( 79 ) . Fixed cremaster muscles were stained with Giemsa and analyzed for the number of intravascular and perivascular leukocytes using an upright microscope (Axioskop; Carl Zeiss, Inc.) through a 100 × 1.3 NA oil immersion objective. Whole mounts from untreated cremaster muscles prepared from both WT and PLC ␥ 2 Ϫ / Ϫ bone media essentially as previously described ( 10, 11, 73, 75 ) using 100 nM PMA (Sigma-Aldrich), 3 μ M f MLP (Sigma-Aldrich), or 50 ng/ml TNF. fMLPstimulated cells were pretreated with 10 μ M cytochalasin B (CB; SigmaAldrich) for 10 min before cell activation. Where necessary, the reaction was stopped after 10 min (degranulation triggered by CB+f MLP) or 30 min (integrin and Fc receptor-mediated degranulation and spreading responses; TNF-induced integrin up-regulation).
Superoxide release was determined by a real-time cytochrome c (SigmaAldrich) reduction test, as previously described ( 51 ), using a multiplate reader (Multiskan Ascent; Thermo Fisher Scientifi c) in dual wavelength (550 and 540 nm) kinetic measurement mode. To simplify the presentation, unstimulated control values were subtracted from those of stimulated samples. Exocytosis of gelatinase was determined by in-gel gelatinase zymography as previously described ( 10, 46 ) . Cell spreading was assessed after formalin fi xation using an inverted microscope (DMI 6000B; Leica) with a 20 × phase-contrast objective connected to a charge-coupled device camera (DFC480; Leica).
Biochemical and signaling studies. Unstimulated WT and PLC ␥ 2 Ϫ / Ϫ neutrophils were lysed in a 1% Triton X-100 -based lysis buff er ( 11, 73 ) , and their Triton-soluble fraction were boiled in sample buff er, run on SDS-PAGE, and immunoblotted with antibodies against PLC ␥ 2 (Q-20; Santa Cruz Biotechnology, Inc.), PLC ␥ 1 (1249; Santa Cruz Biotechnology, Inc.), or ␤ -actin (AC-74; Sigma-Aldrich), followed by peroxidase-labeled secondary antibodies (GE Healthcare). Where indicated, primary antibodies were preincubated with 0.4 μ g/ml of the relevant blocking peptides (Santa Cruz Biotechnology, Inc.) before incubation with the immunoblotting membrane. Lysates prepared from thymus or spleen cells of WT mice served for comparisons of signal intensity.
Purifi ed recombinant Myc-tagged human PLC ␥ 1 and PLC ␥ 2, expressed in Sf9 insect cells using a baculoviral expression system, were obtained from P. Gierschik (University of Ulm, Ulm, Germany) ( 76 ) . For the quantifi cation (titration) of PLC ␥ 1 and PLC ␥ 2 expression in neutrophils, various amounts of the two recombinant proteins along with murine neutrophil lysates were run on SDS-PAGE and immunoblotted using the aforementioned PLC ␥ 1 and PLC ␥ 2 antibodies as well as an antibody against the Myc epitope (clone 9E10; Santa Cruz Biotechnology, Inc.). The amino acid sequences of the human and murine proteins are practically identical around the putative antibody recognition sites in the cases of both PLC ␥ isoforms, whereas there is hardly any similarity between PLC ␥ 1 and PLC ␥ 2 at the same sites, which justifi es the use of recombinant human PLC ␥ isoforms along with the aforementioned polyclonal antibodies for the quantifi cation of the two murine proteins.
For biochemical signaling experiments, neutrophils were plated on a poly-RGD or immobilized immune complex surface, or they were stimulated by 50 ng/ml TNF, 1 μ g/ml Pam 3 CSK 4 , 10 ng/ml GM-CSF, or 100 ng/ml MIP-2 in Mg 2+ -free media in suspension. After 3-min (MIP-2) or 10-min (all other stimuli) incubations, the reaction was stopped and cell lysates were prepared in a Triton X-100 -based lysis buff er ( 11, 73 ) , except for immunoprecipitation assays where the lysis buff er was supplemented with 0.1% SDS and 0.5% sodium deoxycholate (RIPA). PLC ␥ 2 was precipitated using the Q-20 PLC ␥ 2 antibody and captured using a 1:1 mixture of protein A Sepharose (Invitrogen) and protein G Agarose (Invitrogen). Triton-soluble whole-cell lysates or PLC ␥ 2 immunoprecipitates were immunoblotted with antibodies against phosphotyrosine (clone 4G10; Millipore), PLC ␥ 2, p38 MAP kinase In vitro and in vivo migration. In vitro migration of neutrophils was assessed by a Transwell assay system essentially as previously described ( 10, 11 ) . In brief, Transwell inserts with polycarbonate fi lters of 3-μ m pore size (Corning) were precoated with human fi brinogen, fi lled with suspensions of WT or PLC ␥ 2 Ϫ / Ϫ murine neutrophils, and inserted in 24-well plate wells fi lled with assay media containing varying concentrations of f MLP. The K/B × N serum transfer arthritis. Mice carrying the KRN T cell receptor transgene ( 25 ) on the C57BL/6 genetic background were mated with NOD mice to obtain KRN transgene-positive off springs on the C57BL/6 × NOD F1 genetic background (K/B × N mice) as well as their transgene-negative (B × N) littermates. The presence of the transgene was determined by fl ow cytometry as well as by looking for visible signs of arthritis in the K/B × N mice. Blood was taken by retroorbital bleeding and sera from transgenepositive and transgene-negative mice were pooled separately.
Arthritis was induced by intraperitoneal injection of 400 μ l of arthritogenic (K/B × N) or control serum into WT or PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras or intact (nonchimeric) mice, followed by daily assessment of arthritis development for 2 wk. Visible clinical signs of arthritis were scored on a 0 -10 scale by two investigators blinded for the origin and treatment of the mice. Ankle thickness was measured by a spring-loaded caliper (Kroeplin). For histological analysis, mice were killed 4 d after serum transfer and their ankle joints were fi xed in formalin (Sigma-Aldrich). The joints were then decalcifi ed, embedded in paraffi n, sectioned, and stained with hematoxylin and eosin (Histopathology Llc.). Photomicrographs were taken on a microscope (DMI 6000B; Leica).
To assess articular function, mice were placed on a custom-made wire grid (Charles River Laboratories) with identical wire thickness and spacing to a regular wire cage lid. The wire grid was fl ipped upside down and the length of time the mice held on to the grid was recorded. This test was performed three times daily during the period of 8 -12 d after the serum injection. The obtained data were combined into holding-on curves similar to Kaplan-Meier survival curves.
Online supplemental information. Fig. S1 shows expression level of PLC ␥ isoforms in neutrophils and provides detailed information about PLC ␥ antibody specifi city. Fig. S2 shows repopulation of PLC ␥ 2 Ϫ / Ϫ bone marrow chimeras by donor-derived neutrophils after bone marrow transplantation. Fig. S3 shows functional responses of neutrophils from intact (nonchimeric) PLC ␥ 2 Ϫ / Ϫ mice. Fig. S4 shows CD18-dependent activation of adherent neutrophils by various proinfl ammatory agonists. Table S1 shows hemodynamic and microvascular parameters in f MLP-stimulated cremaster muscle venules. Online supplemental material is available at http://www.jem.org/ cgi/content/full/jem.20081859/DC1.
